Xemperia

Description

Xemperia develops blood-based diagnostic tests that detect cancer-associated biomarkers using multiomics and AI methods, and creates DNA-based nanosensors for rapid, sensitive detection of RNA/DNA for cancer detection and monitoring.

Related

• AbridgeAbridge builds an AI assistant that turns clinical conversations into draft and billable documentation for clinicians, nursing teams, and…
• Adaptive Biotechnologies ($ADPT)Adaptive Biotechnologies develops immune-system-based diagnostics and data tools, including NGS MRD testing, for clinicians and biopharma…
• Age LabsAge Labs develops epigenetic biomarkers and predictive algorithms for early detection of age-related diseases and drug response, providing…
• Ångström AIÅngström AI develops diagnostics using amplicon sequencing and machine learning, aiming to broaden access to sequencing-based diagnostic…
• APCAPC builds accelerated drug process development services and technologies for small and large pharmaceutical and biotech companies,…
• Archangel HealthArchangel Health provide infrastructure software that powers medical artificial intelligence systems, helping healthcare teams operate…
• AsimovAsimov designs and delivers integrated cells, genetic constructs, and cloud software to enable commercial-grade cell line and viral vector…
• Atlas DiscoveryAtlas Discovery builds autonomous agents to find new disease uses for existing drugs, support more efficient clinical trials, and present…
• Atomic AIAtomic AI develops machine-learning and structural-biology tools for RNA drug discovery, supporting RNA-targeted small molecules, RNA-based…